|
US2643653A
(en)
|
1951-07-19 |
1953-06-30 |
Heidrich John |
Pill injector
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
FR2504010B1
(fr)
|
1981-04-15 |
1985-10-25 |
Sanofi Sa |
Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
US5272065A
(en)
|
1983-10-20 |
1993-12-21 |
Research Foundation Of State University Of New York |
Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
|
|
US6022950A
(en)
|
1984-06-07 |
2000-02-08 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
US4542225A
(en)
|
1984-08-29 |
1985-09-17 |
Dana-Farber Cancer Institute, Inc. |
Acid-cleavable compound
|
|
US4659839A
(en)
|
1984-10-10 |
1987-04-21 |
Mallinckrodt, Inc. |
Coupling agents for radiolabeled antibody fragments
|
|
ATE66469T1
(de)
|
1985-01-14 |
1991-09-15 |
Neorx Corp |
Metall-radionuklid markiertes protein fuer diagnose und therapie.
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
|
US4892827A
(en)
|
1986-09-24 |
1990-01-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
|
|
US6051405A
(en)
|
1986-09-24 |
2000-04-18 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Constructs encoding recombinant antibody-toxin fusion proteins
|
|
US5807832A
(en)
|
1987-06-09 |
1998-09-15 |
Biotech Australia Pty Limited |
Oral delivery of biologically active substances bound to vitamin B12
|
|
US5997856A
(en)
|
1988-10-05 |
1999-12-07 |
Chiron Corporation |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
|
|
US6780613B1
(en)
|
1988-10-28 |
2004-08-24 |
Genentech, Inc. |
Growth hormone variants
|
|
DK0531434T3
(da)
|
1990-05-11 |
2000-01-31 |
Us Health |
Forbedrede Pseudomonas-exotoksiner med lav dyretoksicitet og høj cytocidal aktivitet
|
|
ES2074879T3
(es)
|
1991-01-16 |
1995-09-16 |
Schering Corp |
Uso de interleuquina-10 en inmunoterapia adoptiva de cancer.
|
|
GB9112553D0
(en)
|
1991-06-11 |
1991-07-31 |
Wellcome Found |
Fusion proteins
|
|
US6613332B1
(en)
|
1991-06-21 |
2003-09-02 |
The University Of Cincinnati |
Oral administration of therapeutic proteins
|
|
DK0590060T3
(da)
|
1991-06-21 |
1998-05-11 |
Univ Cincinnati |
Oralt indgivelige terapeutiske proteiner samt fremgangsmåde til fremstilling
|
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
|
WO1993025690A1
(en)
|
1992-06-18 |
1993-12-23 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Recombinant pseudomonas exotoxin with increased activity
|
|
US20020034727A1
(en)
|
1992-11-02 |
2002-03-21 |
Genentech, Inc. |
Compaction assay for assessment of respiratory disease therapy
|
|
JP3946246B2
(ja)
|
1993-02-02 |
2007-07-18 |
ゾーマ・コーポレイション |
殺菌性／浸透性増大タンパク質（Ｂａｃｔｅｒｉｃｉｄａｌ／Ｐｅｒｍｅａｂｉｌｉｔｙ Ｉｎｃｒｅａｓｉｎｇ ｐｒｏｔｅｉｎ：ＢＰＩ）及び界面活性剤を含有する医薬組成物
|
|
US5328989A
(en)
*
|
1993-03-05 |
1994-07-12 |
Schering-Plough |
Purification of human interleukin-10 from a cell culture medium
|
|
GB9401787D0
(en)
|
1994-01-31 |
1994-03-23 |
Medeva Holdings Bv |
Vaccine compositions
|
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
|
GB9420355D0
(en)
|
1994-10-10 |
1994-11-23 |
Univ Nottingham |
Preparation of protein microspheres, films and coatings
|
|
US5656730A
(en)
|
1995-04-07 |
1997-08-12 |
Enzon, Inc. |
Stabilized monomeric protein compositions
|
|
US5811409A
(en)
|
1995-06-05 |
1998-09-22 |
Synsorb Biotech, Inc. |
Treatment of cholera
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
US5922680A
(en)
|
1996-10-23 |
1999-07-13 |
Ferring, B.V. |
Stabilized composition for oral administration of peptides
|
|
US6391296B1
(en)
|
1997-08-01 |
2002-05-21 |
Toray Industries, Inc. |
Method of stabilizing useful protein and useful protein compositions
|
|
US6342611B1
(en)
|
1997-10-10 |
2002-01-29 |
Cytovia, Inc. |
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
|
|
US6251392B1
(en)
|
1997-10-20 |
2001-06-26 |
Epicyte Pharmaceuticals, Inc. |
Epithelial cell targeting agent
|
|
US6592847B1
(en)
|
1998-05-14 |
2003-07-15 |
The General Hospital Corporation |
Intramolecularly-quenched near infrared flourescent probes
|
|
US6565856B1
(en)
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US7053200B1
(en)
|
1999-06-01 |
2006-05-30 |
Baylor College Of Medicine |
Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
|
|
CZ20021186A3
(cs)
|
1999-10-04 |
2002-11-13 |
Chiron Corporation |
Farmaceutické prostředky obsahující stabilizovaný kapalný polypeptid
|
|
US6838553B1
(en)
|
1999-10-05 |
2005-01-04 |
Academia Sinica |
Peptide repeat immunogens
|
|
DE60043070D1
(de)
|
1999-10-22 |
2009-11-12 |
Genentech Inc |
Proteine-abgabe durch polare epithelzellen schichte
|
|
US20030186386A1
(en)
|
2000-02-11 |
2003-10-02 |
Hansen Christian Karsten |
Interleukin 10
|
|
IL152804A0
(en)
|
2000-05-16 |
2003-06-24 |
Bolder Biotechnology Inc |
Methods for refolding proteins containing free cysteine residues
|
|
DK1379273T3
(da)
|
2000-11-27 |
2009-11-09 |
Powderject Vaccines Inc |
Nukleinsyreadjuvanser
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
US20040116663A1
(en)
*
|
2001-01-16 |
2004-06-17 |
Soren Buus |
Method for refolding of proteins
|
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
|
CA2447795A1
(en)
|
2001-05-23 |
2002-11-28 |
Duotol Ab |
Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
|
|
US20040219240A1
(en)
*
|
2001-06-20 |
2004-11-04 |
Babish John G. |
Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
|
|
ATE408414T1
(de)
|
2001-07-31 |
2008-10-15 |
Us Gov Health & Human Serv |
Glp 1 exendin 4 peptidanaloga und deren verwendungen
|
|
MXPA04008100A
(es)
*
|
2002-02-21 |
2005-06-17 |
Biovail Lab Int Srl |
Formulaciones de liberacion modificada de al menos una forma de tramadol.
|
|
WO2003102132A2
(en)
|
2002-04-26 |
2003-12-11 |
Genetech, Inc. |
Non-affinity purification of proteins
|
|
EP1382614A1
(en)
|
2002-07-15 |
2004-01-21 |
Bayer HealthCare AG |
Process for the purification of interleukin-4 and its muteins
|
|
EP1589951B1
(en)
*
|
2003-01-03 |
2017-08-09 |
Supernus Pharmaceuticals, Inc. |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
|
|
JP4623625B2
(ja)
|
2003-07-24 |
2011-02-02 |
株式会社AMBiS |
ヘテロ型５量体組換えワクチン
|
|
EP1522585A1
(en)
|
2003-10-09 |
2005-04-13 |
Plant Research International B.V. |
Chimeric carrier molecules for the production of mucosal vaccines
|
|
WO2006073446A2
(en)
|
2004-04-28 |
2006-07-13 |
The Trustees Of The University Of Pennsylvania |
Peptide-mediated protein transduction into cells the hematopoietic lineage
|
|
US7632924B2
(en)
|
2004-06-18 |
2009-12-15 |
Ambrx, Inc. |
Antigen-binding polypeptides and their uses
|
|
US20050281885A1
(en)
|
2004-06-21 |
2005-12-22 |
Egilmez Nejat K |
Method for treating inflammatory bowel disease by oral administration of IL-10
|
|
WO2006020580A2
(en)
*
|
2004-08-09 |
2006-02-23 |
Alios Biopharma Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
|
AU2005294436A1
(en)
|
2004-10-04 |
2006-04-20 |
Trinity Biosystems, Inc. |
Methods and compositions for immunizing against Pseudomonas infection
|
|
US20090285771A1
(en)
|
2004-10-04 |
2009-11-19 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of macromolecules
|
|
WO2006135428A2
(en)
|
2004-10-04 |
2006-12-21 |
Trinity Biosystems, Inc. |
Methods and compositions for inducing an immune response against multiple antigens
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
US7964200B2
(en)
|
2005-05-18 |
2011-06-21 |
Children's Hospital & Research Center At Oakland |
Methods and compositions for immunizing against Chlamydia infection
|
|
ES2372537T3
(es)
|
2005-07-29 |
2012-01-23 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services |
Exotoxinas de pseudomonas mutadas con antigenicidad reducida.
|
|
WO2007029238A2
(en)
|
2005-09-06 |
2007-03-15 |
Oramed Pharmaceuticals, Inc. |
Methods and compositions for oral administration of proteins
|
|
WO2007067596A2
(en)
|
2005-12-05 |
2007-06-14 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of antibodies
|
|
WO2007067597A2
(en)
|
2005-12-05 |
2007-06-14 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of binding partners
|
|
WO2008039553A1
(en)
|
2006-02-10 |
2008-04-03 |
Zymogenetics, Inc. |
Soluble il-17rcx4 and methods of using in inflammation
|
|
WO2007109110A2
(en)
|
2006-03-16 |
2007-09-27 |
Trinity Biosystems, Inc. |
Methods for increasing the size of animals using needleless delivery constructs
|
|
US8993295B2
(en)
|
2006-07-20 |
2015-03-31 |
The General Hospital Corporation |
Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting
|
|
US20090092660A1
(en)
|
2006-08-09 |
2009-04-09 |
Trinity Biosystems, Inc. |
Methods and compositions for needleless delivery of particles
|
|
WO2008023050A1
(en)
|
2006-08-25 |
2008-02-28 |
Novo Nordisk A/S |
Acylated exendin-4 compounds
|
|
WO2008045486A2
(en)
|
2006-10-09 |
2008-04-17 |
The University Of North Carolina At Chapel Hill |
Nanoparticle compositions for controlled delivery of nucleic acids
|
|
US20100143481A1
(en)
|
2006-11-08 |
2010-06-10 |
Dinesh Shenoy |
Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
|
|
EP2051702A1
(en)
|
2007-01-22 |
2009-04-29 |
Novavax, Inc. |
Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability
|
|
ES2393814T3
(es)
|
2007-04-04 |
2012-12-28 |
Sigmoid Pharma Limited |
Una composición farmacéutica oral
|
|
WO2008147526A1
(en)
|
2007-05-23 |
2008-12-04 |
The Trustees Of The University Of Pennsylvania |
Targeted carriers for intracellular drug delivery
|
|
US8524241B2
(en)
|
2007-07-20 |
2013-09-03 |
The General Hospital Corporation |
Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A
|
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术（上海）有限公司 |
白介素-22在治疗脂肪肝中的应用
|
|
WO2009026328A2
(en)
|
2007-08-21 |
2009-02-26 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
|
EP2268313A2
(en)
|
2008-03-17 |
2011-01-05 |
Universitätsklinikum Münster |
Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
|
|
WO2009149281A1
(en)
|
2008-06-04 |
2009-12-10 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Immunotoxins and uses thereof
|
|
NO2344540T3
(https=)
|
2008-10-02 |
2018-04-28 |
|
|
|
JP2012533587A
(ja)
|
2009-07-22 |
2012-12-27 |
セニックス バイオサイエンス ゲーエムベーハー |
自然に存在する細胞内輸送経路を介して化合物を送達するための送達システム及びコンジュゲート
|
|
NZ597964A
(en)
|
2009-07-31 |
2014-04-30 |
Sanofi Aventis Deutschland |
Long acting insulin composition
|
|
WO2011031441A1
(en)
|
2009-08-28 |
2011-03-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Therapy with a chimeric molecule and a pro-apoptotic agent
|
|
KR101820374B1
(ko)
*
|
2010-02-23 |
2018-01-19 |
다 볼떼라 |
장 내 흡착제의 경구 전달을 위한 제형
|
|
CN101891823B
(zh)
|
2010-06-11 |
2012-10-03 |
北京东方百泰生物科技有限公司 |
一种Exendin-4及其类似物融合蛋白
|
|
US11246915B2
(en)
|
2010-09-15 |
2022-02-15 |
Applied Molecular Transport Inc. |
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
|
RU2593715C2
(ru)
|
2010-09-15 |
2016-08-10 |
Рэндэлл Дж. МРСНИ |
Системы и способы доставки биоактивных средств с применением транспортных последовательностей, происходящих от бактериального токсина
|
|
US8697132B2
(en)
*
|
2010-12-01 |
2014-04-15 |
Shire Llc |
Capsule and powder formulations containing lanthanum compounds
|
|
US20140065172A1
(en)
|
2011-01-26 |
2014-03-06 |
Cenix Bioscience Gmbh |
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
|
WO2012110596A1
(en)
|
2011-02-16 |
2012-08-23 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Fusion protein for the treatment of immunologic or allergic reactions
|
|
PL2726091T3
(pl)
|
2011-06-29 |
2020-08-10 |
Rani Therapeutics, Llc |
Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek
|
|
US8877161B2
(en)
|
2011-10-19 |
2014-11-04 |
Georgia Regents Research Institute, Inc. |
GM1-like peptides and uses thereof
|
|
EP2820033A1
(en)
|
2012-02-29 |
2015-01-07 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates and their uses
|
|
SG11201407860PA
(en)
|
2012-06-14 |
2014-12-30 |
Sanofi Sa |
Exendin-4 peptide analogues
|
|
BR112015014836A2
(pt)
|
2012-12-21 |
2017-07-11 |
Verlyx Pharma Inc |
método para tratamento alvo de uma ou mais condições do fígado, e, uso oral de uma quantidade terapeuticamente eficaz de pelo menos um análogo de diamidina ou um sal farmaceuticamente aceitável da mesma
|
|
AU2013366692B2
(en)
|
2012-12-21 |
2017-11-23 |
Sanofi |
Dual GLP1/GIP or trigonal GLP1/GIP/Glucagon agonists
|
|
WO2014145016A2
(en)
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
|
EP2989240A4
(en)
|
2013-04-24 |
2016-10-19 |
Armo Biosciences Inc |
INTERLEUKIN-10 COMPOSITIONS AND USES THEREOF
|
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术（上海）有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
|
ES2739129T5
(es)
|
2013-11-07 |
2024-04-02 |
Memorial Sloan Kettering Cancer Center |
IL-22 para uso en el tratamiento de la enfermedad gastrointestinal del injerto contra el huesped
|
|
CN120242030A
(zh)
|
2013-11-11 |
2025-07-04 |
阿尔莫生物科技股份有限公司 |
将白细胞介素-10用于治疗疾病和病症的方法
|
|
WO2015086733A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Dual glp-1/glucagon receptor agonists
|
|
MX2016008979A
(es)
|
2014-01-09 |
2016-10-04 |
Sanofi Sa |
Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina.
|
|
CN112851769A
(zh)
|
2014-01-27 |
2021-05-28 |
分子模板公司 |
用于哺乳动物中的去免疫化志贺毒素a亚基效应子多肽
|
|
CN106470707A
(zh)
|
2014-05-07 |
2017-03-01 |
应用分子运输有限责任公司 |
用于口服递送生物活性货物的cholix毒素衍生的融合分子
|
|
AU2015257589A1
(en)
*
|
2014-05-09 |
2016-11-24 |
Nogra Pharma Limited |
Methods for treating inflammatory bowel disease
|
|
EP3179985A1
(en)
|
2014-08-14 |
2017-06-21 |
Brown University |
Compositions for stabilizing and delivering proteins
|
|
AU2015336101A1
(en)
|
2014-10-22 |
2017-04-20 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
TWI806150B
(zh)
|
2014-11-07 |
2023-06-21 |
瑞士商諾華公司 |
穩定的含有高濃度抗vegf抗體之蛋白質溶液調配物
|
|
US20170362291A1
(en)
*
|
2014-12-23 |
2017-12-21 |
Armo Biosciences, Inc. |
Methods of Improving Yield in Recombinant Protein Production
|
|
DK3244878T3
(da)
*
|
2015-01-12 |
2022-10-17 |
Enteris Biopharma Inc |
Faste orale sammensætningsformer
|
|
WO2016146833A1
(en)
|
2015-03-19 |
2016-09-22 |
F. Hoffmann-La Roche Ag |
Biomarkers for nad(+)-diphthamide adp ribosyltransferase resistance
|
|
CA2993823C
(en)
|
2015-07-28 |
2024-01-02 |
Board Of Regents, The University Of Texas System |
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
|
|
WO2017062920A1
(en)
|
2015-10-07 |
2017-04-13 |
Chopra Sunandini |
Nanoparticles with ph triggered drug release
|
|
US12241053B2
(en)
|
2015-10-09 |
2025-03-04 |
The Brigham And Women's Hospital, Inc. |
Modulation of novel immune checkpoint targets
|
|
US10828318B2
(en)
|
2016-01-06 |
2020-11-10 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
|
EP3192805A1
(en)
|
2016-01-15 |
2017-07-19 |
Humanitas Mirasole S.p.A. |
Inhibitors of t cell activation or stimulation and uses thereof
|
|
WO2017210684A1
(en)
|
2016-06-03 |
2017-12-07 |
New York University |
Methods and reagents for modulating macrophage phenotype
|
|
WO2018005226A2
(en)
|
2016-06-22 |
2018-01-04 |
Alkermes, Inc. |
Compositions and methods for modulating il-10 immunostimulatory and anti-inflammatory properties
|
|
WO2018015380A1
(en)
|
2016-07-18 |
2018-01-25 |
Philippe Ulsemer |
Natural microorganisms which are naturally capable of binding toxins and/or toxin receptors
|
|
JP7179354B2
(ja)
|
2016-08-29 |
2022-11-29 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
皮膚処置のためのイオン種に基づく局所処方物
|
|
IL314380A
(en)
|
2016-10-06 |
2024-09-01 |
Orbus Therapeutics Inc |
Preparations for administration of aflornithine
|
|
WO2018106895A1
(en)
|
2016-12-07 |
2018-06-14 |
Molecular Templates, Inc. |
Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
|
|
EP3554541B1
(en)
|
2016-12-14 |
2023-06-07 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
|
JP2020513280A
(ja)
|
2016-12-14 |
2020-05-14 |
プロジェニティ， インコーポレイテッド |
消化管疾病の免疫抑制剤による治療
|
|
WO2019036243A1
(en)
|
2017-08-16 |
2019-02-21 |
Molecular Infusions, Llc |
Formulations
|
|
WO2018175340A1
(en)
|
2017-03-20 |
2018-09-27 |
Sienna Biopharmaceuticals, Inc. |
Reduced exposure conjugates modulating therapeutic targets
|
|
US20200048321A1
(en)
|
2017-03-24 |
2020-02-13 |
Orpheus Bioscience Inc. |
Pantids for treatment of autoimmune disorders
|
|
CA3054156A1
(en)
|
2017-03-30 |
2018-10-04 |
Progenity Inc. |
Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist
|
|
US20200323772A1
(en)
|
2017-08-15 |
2020-10-15 |
Progenity, Inc. |
Treatment of inflammatory disease using ingestible device to release immune modulator
|
|
US11674950B2
(en)
|
2017-10-31 |
2023-06-13 |
Dana-Farber Cancer Institute, Inc. |
Methods determining and treating cellular resistance to ADP-rtbosylating toxin
|
|
CN121513216A
(zh)
|
2018-03-08 |
2026-02-13 |
应用分子转运公司 |
用于经口递送的毒素衍生的递送构建体
|
|
WO2019173787A1
(en)
*
|
2018-03-08 |
2019-09-12 |
Applied Molecular Transport Inc. |
Toxin-derived delivery constructs for oral delivery
|
|
WO2019183449A1
(en)
|
2018-03-23 |
2019-09-26 |
North Carolina State University |
Methods and compositions for allergic disorders
|
|
WO2019193204A1
(en)
|
2018-04-06 |
2019-10-10 |
Cyprumed Gmbh |
Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
|
|
WO2020023389A1
(en)
|
2018-07-23 |
2020-01-30 |
Sienna Biopharmaceuticals, Inc. |
Reduced exposure compositions modulating therapeutic targets
|
|
EP3610862A1
(en)
|
2018-08-14 |
2020-02-19 |
Apillet APS |
Novel oral composition
|
|
EP4083058A3
(en)
|
2018-11-07 |
2023-01-11 |
Applied Molecular Transport Inc. |
Delivery constructs for transcytosis and related methods
|
|
US20200140511A1
(en)
|
2018-11-07 |
2020-05-07 |
Applied Molecular Transport Inc. |
Delivery constructs for transcytosis and related methods
|
|
WO2020096695A1
(en)
|
2018-11-07 |
2020-05-14 |
Applied Molecular Transport Inc. |
Cholix-derived carriers for oral delivery of heterologous payload
|
|
WO2020144164A1
(en)
|
2019-01-07 |
2020-07-16 |
Bactolife Aps |
Pathogen binding proteins
|
|
BR112021022429A2
(pt)
|
2019-05-10 |
2022-03-22 |
Glaxosmithkline Biologicals Sa |
Produção de conjugados
|
|
MX2022001975A
(es)
|
2019-08-16 |
2022-03-11 |
Applied Molecular Transport Inc |
Composiciones, formulaciones y produccion y purificacion de interleucinas.
|
|
TW202120529A
(zh)
|
2019-08-16 |
2021-06-01 |
美商應用分子運輸公司 |
用於遞送負載物之組合物及顆粒
|
|
WO2021155281A1
(en)
|
2020-01-31 |
2021-08-05 |
Applied Molecular Transport Inc. |
Compositions and methods for treatment of celiac disease
|